CDK9 inhibitor HH1

CAS No. 204188-41-0

CDK9 inhibitor HH1 ( —— )

Catalog No. M13175 CAS No. 204188-41-0

CDK9 inhibitor HH1 is a novel potent, highly selective CDK9 inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 76 Get Quote
10MG 104 Get Quote
25MG 168 Get Quote
50MG 246 Get Quote
100MG 357 Get Quote
500MG 851 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CDK9 inhibitor HH1
  • Note
    Research use only, not for human use.
  • Brief Description
    CDK9 inhibitor HH1 is a novel potent, highly selective CDK9 inhibitor.
  • Description
    CDK9 inhibitor HH1 is a novel potent, highly selective CDK9 inhibitor.
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    CDK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    204188-41-0
  • Formula Weight
    261.34
  • Molecular Formula
    C13H15N3OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)NC1=NC(=C(S1)C(=O)C2=CC=CC=C2)N
  • Chemical Name
    (4-amino-2-(isopropylamino)thiazol-5-yl)(phenyl)methanone

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhang H, et al. Cell. 2018 Nov 15;175(5):1244-1258.e26.
molnova catalog
related products
  • SEL120-34A

    SEL120-34A is an ATP-competitive, selective, orally active CDK8 inhibitor that inhibits kinase activities of CDK8/CycC and CDK19/CycC complexes with IC50 of 4.4 nM and 10.4 nM, respectively.

  • GW-8510

    GW-8510 (GW8510) is apotent, selective inhibitor of CDK2 with IC50 of 10 nM; displays weak inhibition for CDK1 and CDK4 (IC50=110 and 130 nM, respectively) in vitro biochemical assays.

  • Indisulam

    Indisulam (E7070) is potent, sulfonamide, cell-cycle inhibitor that possesses antiproliferative activities, causes decrease in the S phase fraction along with G1 and/or G2 accumulation in various cancer cell lines.